Home › Trials › NCT02012699

A resource for collecting cancer data and biospecimens

Integrated Cancer Repository for Cancer Research

University of Nebraska · NCT02012699

This study is creating a resource to collect health information and samples from cancer patients and healthy individuals to help improve cancer prevention and treatment strategies.

Quick facts

Study typeObservational
Enrollment999999 (estimated)
Ages19 Years to 110 Years
SexAll
SponsorUniversity of Nebraska (other)
Locations42 sites (Greenwood Village, Colorado and 41 other locations)
Trial IDNCT02012699 on ClinicalTrials.gov

What this trial studies

The iCaRe2 is a multi-institutional resource developed by the Fred & Pamela Buffett Cancer Center to gather and manage standardized, longitudinal data and biospecimens from adult cancer patients, high-risk individuals, and normal controls. This initiative focuses on a wide geographical coverage, including small and rural hospitals, to enhance studies on cancer risk factors and to facilitate the development of innovative strategies for prevention, screening, and personalized treatment. The repository supports collaboration among centers with expertise in various cancer-related fields, allowing for comprehensive cohort and population studies.

Who should consider this trial

Good fit: Ideal candidates include adults with a personal history of cancer, those at high risk for developing cancer, and individuals without a cancer history for the control registry.

Not a fit: Patients under 19 years of age or those unable to provide informed consent due to cognitive impairment may not benefit from this study.

Why it matters

Potential benefit: If successful, this initiative could lead to improved cancer prevention, early detection, and personalized treatment strategies for patients.

How similar studies have performed: Other studies utilizing similar data collection and biospecimen management approaches have shown promise, indicating potential for success in this novel initiative.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria

* Diagnosis/history of cancer
* Risk for developing cancer or suspicious clinical findings
* No history of cancer (normal control registry)
* Able to provide informed consent
* 19 years of age or older
* English or Spanish speaking individuals

Exclusion Criteria

* Unable to provide informed consent because of cognitive impairment
* Non-English or non-Spanish speaking individuals

Where this trial is running

Greenwood Village, Colorado and 41 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Pancreatic Cancer, Thyroid Cancer, Lung Cancer, Esophageal Cancer, Thymus Cancer, Colon Cancer, Rectal Cancer, Gastrointestinal Stromal Tumors

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.